LT3632912T - Piridochinazolino dariniai, naudingi kaip proteinkinazės inhibitoriai - Google Patents

Piridochinazolino dariniai, naudingi kaip proteinkinazės inhibitoriai

Info

Publication number
LT3632912T
LT3632912T LTEP18759146.6T LT18759146T LT3632912T LT 3632912 T LT3632912 T LT 3632912T LT 18759146 T LT18759146 T LT 18759146T LT 3632912 T LT3632912 T LT 3632912T
Authority
LT
Lithuania
Prior art keywords
pyridochinazoline
derivatives used
proteinkinase inhibitors
proteinkinase
inhibitors
Prior art date
Application number
LTEP18759146.6T
Other languages
English (en)
Lithuanian (lt)
Inventor
Guido Kurz
Juan Camacho Gomez
Original Assignee
Oncostellae, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncostellae, S.L. filed Critical Oncostellae, S.L.
Publication of LT3632912T publication Critical patent/LT3632912T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24CDOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
    • F24C7/00Stoves or ranges heated by electric energy
    • F24C7/08Arrangement or mounting of control or safety devices
    • F24C7/082Arrangement or mounting of control or safety devices on ranges, e.g. control panels, illumination
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24CDOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
    • F24C7/00Stoves or ranges heated by electric energy
    • F24C7/08Arrangement or mounting of control or safety devices
    • F24C7/087Arrangement or mounting of control or safety devices of electric circuits regulating heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Combustion & Propulsion (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LTEP18759146.6T 2017-06-01 2018-05-31 Piridochinazolino dariniai, naudingi kaip proteinkinazės inhibitoriai LT3632912T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201730759 2017-06-01
PCT/ES2018/070396 WO2018220252A1 (es) 2017-06-01 2018-05-31 Derivados de piridoquinazolina eficaces como inhibidores de proteína quinasa

Publications (1)

Publication Number Publication Date
LT3632912T true LT3632912T (lt) 2021-06-10

Family

ID=61569288

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP18759146.6T LT3632912T (lt) 2017-06-01 2018-05-31 Piridochinazolino dariniai, naudingi kaip proteinkinazės inhibitoriai

Country Status (22)

Country Link
US (1) US11021479B2 (enExample)
EP (1) EP3632912B1 (enExample)
JP (1) JP7110335B2 (enExample)
KR (1) KR102629854B1 (enExample)
CN (1) CN111247143B (enExample)
AU (1) AU2018278283B2 (enExample)
CA (1) CA3066009A1 (enExample)
CY (1) CY1124087T1 (enExample)
DK (1) DK3632912T3 (enExample)
EA (1) EA037384B1 (enExample)
ES (1) ES2881960T3 (enExample)
HR (1) HRP20210814T1 (enExample)
HU (1) HUE054792T2 (enExample)
LT (1) LT3632912T (enExample)
MX (1) MX385475B (enExample)
PL (1) PL3632912T3 (enExample)
PT (1) PT3632912T (enExample)
RS (1) RS61833B1 (enExample)
SI (1) SI3632912T1 (enExample)
SM (1) SMT202100312T1 (enExample)
WO (1) WO2018220252A1 (enExample)
ZA (1) ZA201908372B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7525609B2 (ja) 2020-01-31 2024-07-30 エルジー エナジー ソリューション リミテッド 多層構造の無機物層を含む分離膜一体型電極の製造方法及びそれによる分離膜一体型電極

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551460A (en) 1982-05-10 1985-11-05 Hoffmann-La Roche Inc. Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
EP0944628B1 (en) * 1996-11-26 2002-06-05 American Cyanamid Company Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents
US20050171172A1 (en) * 2003-11-13 2005-08-04 Ambit Biosciences Corporation Amide derivatives as PDGFR modulators
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
KR101361027B1 (ko) 2008-11-28 2014-02-11 코와 가부시키가이샤 피리딘-3-카르복시아미드 유도체
US11001581B2 (en) 2014-03-20 2021-05-11 The Johns Hopkins University and Lieber Institute, Inc. Compounds which inhibit RNA polymerase, compositions including such compounds, and their use

Also Published As

Publication number Publication date
RS61833B1 (sr) 2021-06-30
EA201992793A1 (ru) 2020-03-26
EA037384B1 (ru) 2021-03-23
HRP20210814T1 (hr) 2021-06-25
CA3066009A1 (en) 2018-12-06
CN111247143B (zh) 2022-07-05
SMT202100312T1 (it) 2021-07-12
EP3632912B1 (en) 2021-03-17
JP7110335B2 (ja) 2022-08-01
ES2881960T3 (es) 2021-11-30
JP2020521817A (ja) 2020-07-27
MX385475B (es) 2025-03-18
CN111247143A (zh) 2020-06-05
US20200148676A1 (en) 2020-05-14
US11021479B2 (en) 2021-06-01
DK3632912T3 (da) 2021-05-10
MX2019014436A (es) 2020-02-10
AU2018278283B2 (en) 2021-06-17
KR20200011990A (ko) 2020-02-04
SI3632912T1 (sl) 2021-08-31
KR102629854B1 (ko) 2024-01-25
CY1124087T1 (el) 2022-05-27
PL3632912T3 (pl) 2021-09-06
PT3632912T (pt) 2021-06-02
HUE054792T2 (hu) 2021-09-28
EP3632912A1 (en) 2020-04-08
WO2018220252A1 (es) 2018-12-06
AU2018278283A1 (en) 2019-12-19
BR112019024892A2 (pt) 2020-06-16
ZA201908372B (en) 2021-04-28

Similar Documents

Publication Publication Date Title
LT3580220T (lt) Aminotriazolopiridinai, kaip kinazės inhibitoriai
IL269196A (en) Novel inhibitors
LT3371190T (lt) Heterocikliniai junginiai, kaip pi3k-gama inhibitoriai
LT3464272T (lt) Nauji heterocikliniai dariniai, naudingi kaip shp2 inhibitoriai
DK3298002T3 (da) Heterocykliske amider som kinasehæmmere
DK3328849T3 (da) 1,1,1-trifluor-3-hydroxypropan-2-yl-carbamat-derivater og 1,1,1-trifluor-4-hydroxybutan-2-yl-carbamat-derivater som magl-inhibitorer
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
HUE058009T2 (hu) 1,3-Tiazol-2-il szubsztituált benzamid-származékok
DK3319956T3 (da) Substituerede oxopyridinderivater
DK3324977T3 (da) Benzodiazepinderivater som rsv-inhibitorer
HUE061064T2 (hu) Szelektív JAK1 gátlók
LT3105226T (lt) Ciklopropilaminai, kaip lsd1 inhibitoriai
IL261904A (en) 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
LT3609898T (lt) Junginiai, naudingi kaip ret inhibitoriai
HUE054410T2 (hu) 3-tetrazolil-benzol-1,2-diszulfonamid származékok mint fém-béta-laktamáz inhibitorok
LT3704118T (lt) Aminoimidazopiridazinai, kaip kinazės inhibitoriai
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
EP3684772C0 (en) CYCLIC IMINOPYRIMIDINE DERIVATIVES AS KINASE INHIBITORS
EP3713931C0 (en) 3-OXO-6-HETEROARYL-2-PHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDE
DK3592745T3 (da) Pyrimidopyrimidinoner anvendelige som Wee-1 kinaseinhibitorer
DK3630744T3 (da) Pyrazol-magl-inhibitorer
DK3288931T3 (da) Visse proteinkinaseinhibitorer
DK3458460T3 (da) Imidazoler som histondemethylase-inhibitorer
DK3418275T3 (da) Hidtil ukendt 2,3,5-substitueret thiophenforbindelse som proteinkinasehæmmer